Dual inhibition of STAT3 and STAT5 may overcome imatinib resistance in chronic myeloid leukemia.
Hematology (Amsterdam, Netherlands)（2023）
摘要
SH-4-54 may overcome IM resistance and represent a promising novel approach to improve the outcome of CML.
更多查看译文
关键词
imatinib resistance,stat5,stat3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要